2024/25 Taught Postgraduate Programme Catalogue

MSc Biopharmaceutical Development

Programme overview

Programme code
MSC-BSG/BD
UCAS code
Duration
12 Months
Method of Attendance
Full Time
Programme manager
Dr Dimitra Mitsa
Contact address
D.Mitsa@leeds.ac.uk
Total credits
180
School/Unit responsible for the parenting of students and programme
Faculty of Biological Sciences
Examination board through which the programme will be considered
The Masters Bioscience Exam Board
Relevant QAA Subject Benchmark Groups
Subject benchmark statements for biological sciences Masters programmes do not exist. However, students will be expected to demonstrate the characteristics embodied in the QAA Qualifications Frameworks level descriptors for Masters degrees (https://www.qaa.ac.uk/docs/qaa/quality-code/master's-degree-characteristics-statement.pdf?sfvrsn=6ca2f981_10)

Entry requirements

Entry Requirements are available on the Course Search entry

Programme specification

The programme will provide integrated understanding of the industrial pathway of biological drug discovery, development and exploitation. Modules exist for each of the major technical functions of this industry (discovery, manufacturing, pre-clinical testing, clinical safety and efficacy, laboratory analytical skills). Further modules introduce the course & industry (pathway, regulatory framework, economic value, and societal drivers), to address commercialisation of biopharmaceutical products and a final taught module that integrates topics in the form of project work submitting a new biochemical entity to a regulatory body. This will provide students with a deep understanding of core elements of the discipline, and a good appreciation of the broader context and regulatory framework of the industry. It is highly interdisciplinary, and will equip students to work in such teams.

There will be a strong emphasis on the acquisition of technical skills necessary for biological drug development and so a substantial component of the programme will be devoted to practical training including a taught practical skills module (Practical Skills for a Regulatory Environment). The practical skills module will introduce students to the techniques used in the biopharma industry and the standards to which they are applied within a regulatory environment. Thus students will perform a series of experiments demonstrating stages along the drug development pathway working under GLP/GMP/GCP instruction as far as is possible within university laboratories. Topics covered will include: assay validation (accuracy, precision, robustness, in-specification), followed by two practical strands; one focusing on molecular/biophysical protein characterisation (GMP-focus; antibody purification, SDS-PAGE, bio-potency activity assay by ELISA, binding assay by e.g. SPR) and the second on cell-based assays (GCP-focus; flow cytometry, confocal microscopy, cell growth/viability). During the research project, students will have the opportunity to apply this training, thus building on, and extending these skills.

Year 1

[Learning Outcomes, Transferable (Key) Skills, Assessment]
View Timetable

Compulsory Modules

Candidates will be required to study the following compulsory modules:

CodeTitleCreditsSemesterPass for Progression
BIOL5124MIntroduction to Pharmaceutical Science and Commerce15Semester 1 (Sep to Jan)
BIOL5181MManufacturing Biopharmaceuticals15Semester 1 (Sep to Jan)
BIOL5208MIntegrated Drug Development Plan15Semester 2 (Jan to Jun)
BIOL5210MBiopharmaceutical Development: Clinical15Semester 2 (Jan to Jun)
BIOL5323MPractical Skills for a Regulatory Environment 30Semesters 1 & 2 (Sep to Jun)
BIOL5384MBiopharmaceutical drug discovery and non-clinical testing30Semesters 1 & 2 (Sep to Jun)
BIOL5393MBioscience MSc Research Project601 Feb to 30 SepPFP

Last updated: 29/08/2024 16:04:11

Errors, omissions, failed links etc should be notified to the Catalogue Team